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line MR images.
Results: The mean age of the participants was 26 years, 27% were
female and the mean BMI was 24kg/m2. Over the course of 5 years the
change in curvature was statistically signiﬁcant in each region of the
knee. In each region the values for curvature decreased (Figure).
Participants randomized to early surgery as opposed to rehabilitation
plus optional delayed ACL reconstruction were more likely to have
ﬂatter curvature in the femur (P<.001), medial femoral condyle
(p¼0.006) and trochlea (p¼0.003). Any meniscal injury (largely medial
meniscus) was associated with a more ﬂattened curvature in the femur
(p¼0.001), trochlea (p¼0.011) and lateral femoral condyle (p¼0.038)
and lateral tibia (p¼0.048). In contrast, a lateral tibial osteochondral
fracture was associated with amore convex curvature in the lateral tibia
(p¼0.017).
Conclusions: This study demonstrates that ACL injury leads to signiﬁ-
cant changes in articulating bone curvatures. These changes are
measurable within a short interval (3 months) of the injury. Increased
body mass index, meniscal injury and randomization to surgery (as
distinct from rehabilitation plus optional delayed ACL reconstruction)
all lead to decreased curvature.Figure. Trajectory of bone curvature (1/mm, inverse millimeters) change over the ﬁve
year follow-up period by aratomic location.255
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Purpose: This observational study was designed to examine the
hypothesis that patients with hip osteoarthritis (OA) have a shorter
duration of symptoms but more advanced radiological changes and
more severe symptoms at ﬁrst presentation to our clinic than similar
patients with knee OA.
Methods: This case-comparison study compared 35 consecutive hip OA
patients and 70 (age and sex matched) knee OA patients from a single
tertiary osteoarthritis clinic from 2008 to 2011. BMI, total symptom
duration, duration of presenting complaint, Multi-attribute Arthritis
Prioritisation Tool (MAPT) scores and Modiﬁed Kellgren-Lawrence
(MKL) scores were recorded for each patient's ﬁrst presentation to the
clinic. The MAPT score, designed to prioritise and monitor patients who
may require joint surgery, is a severity score (out of a total of 100)
derived from a standardised patient questionnaire. MKL scores were
converted to ordinal data for statistical analysis. Data for the hip and
knee groups was compared by non-parametric Mann-Whitney U
testing, performed by a statistician who was blinded to the study
hypothesis.
Results: Both groups had similar age, sex and BMI. The hip MAPT score
(median ¼ 71.3, interquartile range 37.9 - 89.6) was signiﬁcantly higher
than the knee MAPT score (median ¼ 36.9, IQR 11.4 - 74.8); mean rank
for hip group was 64.8 and mean rank for knee group was 47.1 (U ¼
1638, p ¼ 0.005). The hip MKL scores (median ¼ 4, IQR 4 - 5) weresigniﬁcantly higher than the knee MKL scores (median 4, IQR 3 - 4);
mean rank for hip group was 65.7 and mean rank for knee group was
46.7 (U¼ 1669.5, p¼ 0.002). The total duration of symptoms for the hip
group (median ¼ 30, IQR 12 - 54 months) was signiﬁcantly less than the
duration of symptom for the knee group (median ¼ 48, IQR 24 - 108
months); mean rank for hip group was 33.6 and mean rank for knee
group was 44.1 (U ¼ 545.5, p ¼ 0.045). The duration of presenting
complaint for the hip group (median ¼ 6, IQR 3.0 - 6.5 months) was
signiﬁcantly less than the duration of presenting complaint for the knee
group (median ¼ 9.5, IQR 5.5 - 12.0 months); mean rank for hip group
was 32.1 and mean rank for knee group was 45.1 (U ¼ 500, p ¼ 0.012).
Conclusions: In this case-comparison study, patients with hip OA
presented after a shorter duration of symptoms with higher MAPT and
MKL scores than their knee OA counterparts. In other words, hip OA
patients were more likely to present earlier to our clinic but were
conversely more likely to have more advanced radiological changes and
worse symptoms (byMAPT score) than knee OA patients. These ﬁndings
support our hypothesis and warrant a larger observational study.256
CONSTRUCT VALIDITY OF PROMIS INSTRUMENTS AMONG PATIENTS
WITH SYMPTOMATIC KNEE OSTEOARTHRITIS
N.L. Morgan, J.B. Driban, G.L. Ransford, L. Price, C. Wang. Tufts Med. Ctr.,
Boston, MA, USA
Purpose: The National Institute of Health's Patient Reported Outcomes
Measurement Information System (PROMIS) provides instruments to
measure patient-reported health status (e.g., anxiety, depression,
physical function). These instruments may allow for an efﬁcient means
to assess various patient-reported outcomes but have not yet been
validated among patients with symptomatic knee osteoarthritis (KOA).
We evaluated the construct validity of PROMIS instruments by exam-
ining correlations with well-validated measures commonly used to
assess patients with KOA.
Methods:We conducted a secondary analysis of baseline data from our
randomized controlled trial comparing Tai Chi and physical therapy
among patients with symptomatic KOA as deﬁned by the American
College of Rheumatology criteria. Patients enrolled in the trial
completed 5 short-form PROMIS instruments (Anxiety, Depression,
Health Assessment Questionnaire [HAQ], Physical Function, and Pain
Impact) as well as corresponding measures that assessed similar
domains. They also performed 2 physical function tests (6-minute walk
test and 20-meter walk test) that were administered by investigators
following a standardized protocol. We determined the construct val-
idity of PROMIS instruments by exploring if PROMIS instruments had
moderate-to-strong correlations (Spearman r > 0.5) with validated
measures that assessed conceptually similar constructs (convergent
validity) compared to validated measures that assessed different
constructs (discriminant validity). Table 1 provides a summary of each
PROMIS instrument and the a priori hypotheses deﬁning their respec-
tive construct, validated measures that assess that construct (for
convergent validity), and validated measures that assess different
constructs (for discriminate validity).
Results: Our analysis included data from 154 patients with an average
age of 60.5 (SD ¼ 10.6) years and body mass index of 32.9 (SD ¼ 7.4) kg/
m2. The sample was 68% female and 92.7% had a Kellgren/Lawrence
grade  2. All correlations were in the hypothesized direction and can
be viewed in Table 2. PROMIS Anxiety and Depression showed good
convergent and discriminant validity among individuals with symp-
tomatic KOA. PROMIS HAQ and Physical Function assessed a similar
construct to the SF-36 Physical Component Summary (PCS) score but
had weaker correlations with the knee-speciﬁc WOMAC function score
and physical function tests. Finally, PROMIS Pain Impact measured
a similar construct as the SF-36 Bodily Pain (BP) score and the Chronic
Pain Self-Efﬁcacy Scale (CPSS) score but was not as strongly correlated
with knee-speciﬁc WOMAC pain scores. Discriminant validity could not
be conﬁrmed for PROMIS HAQ, Physical Function, or Pain Impact.
Conclusions: Our results support the construct validity of PROMIS
Anxiety and Depression in measuring these domains among patients
with symptomatic KOA. While the construct validity of PROMIS HAQ,
Physical Function, and Pain Impact is supported by their strong corre-
lations with the SF-36 PCS, SF-36 BP, and CPSS, respectively, the weaker
correlations seen among the disease-speciﬁc measures suggest that
these PROMIS instruments reﬂect whole-body disease burden and not
joint-speciﬁc pain or function.
